Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update

Go back to Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update
(NYSE: RCUS) Delayed: 29.66 -0.47 (1.56%)
Previous Close $30.13    52 Week High
Open $29.64    52 Week Low
Day High $30.10    P/E N/A 
Day Low $29.40    EPS
Volume 736,983